Pliant Therapeutics (PLRX)

• Market cap: $83M
• 1 day: -4.26%
• 5 days: 3.85%
• 1 month: 21.62%
• 3 months: 8.87%
• 6 months: -11.76%
• Year to date: 8%
• 1 year: -11.18%
• 5 years: -96.47%
• 10 years: -93.66%
• Sector: Healthcare
• Industry: Biotechnology

About: Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Employees: 171